HIVACAR
The IDIBAPS and the Hospital Clínic of Barcelona lead a European project aimed at changing the current paradigm of HIV treatment by obtaining a functional cure. Although there are several prevention strategies that are effective, they are difficult to maintain in the long term. Achieving a functional cure would cause patients to become carriers of the virus at undetectable levels, and although prevention measures would still be necessary, the risk of transmission would be minimized. ZABALA participates in the coordination and management of this ambitious initiative.
This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement Nº 731626
In one click
The functional cure of HIV is one of the main challenges in the fight against it. Achieving a functional cure would cause patients to become carriers of the virus at undetectable levels, and although prevention measures would still be necessary, the risk of transmission would be minimized.
It will be done within the framework of a Phase II clinical trial, to test the combination’s safety and tolerability. It will be determined whether this combination is capable of activating the immune system mechanisms necessary to remove infected cells from the latent viral reservoir. The socioeconomic and psychosocial impact of this treatment will also be analyzed. The main goal is to control HIV replication over long periods of time or throughout life without antiretroviral treatment.
